Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay B Wish

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Kidney International Reports|November 29, 2023
Tenapanor as Add-on Treatment for Hyperphosphatemia in Dialysis Patients: Enough Bang for the Buck?Jay B Wish
Clinical Journal of the American Society of Nephrology : CJASN|August 8, 2018
Biosimilars-Emerging Role in NephrologyJay B Wish
Nephrology News & Issues|July 17, 2013
Management of anemia in patients with kidney disease in 2013 and beyondJay B Wish
Postgraduate Medicine|August 12, 2009
Management of anemia in patients with chronic kidney diseaseJay B Wish
Advances in Chronic Kidney Disease|February 24, 2009
Past, present, and future of chronic kidney disease anemia management in the United StatesJay B Wish
Kidney International Reports|October 8, 2021
Treatment of Anemia in Kidney Disease: Beyond ErythropoietinJay B Wish
Seminars in Dialysis|December 24, 2010
Vascular access for dialysis in the United States: progress, hurdles, controversies, and the futureJay B Wish
Blood Purification|January 14, 2011
What is expected of a medical director in the Centers for Medicare and Medicaid Services Conditions of Coverage?Jay B Wish
Nephrology News & Issues|March 22, 2014
The iron story: red smoke and magnetism?Jay B Wish
Advances in Chronic Kidney Disease|September 4, 2019
Anemia Treatment After 30 Years of Erythropoietic Stimulating Agents: No Longer Business as Usual?Jay B Wish
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Kidney International Reports|November 29, 2023
Tenapanor as Add-on Treatment for Hyperphosphatemia in Dialysis Patients: Enough Bang for the Buck?Jay B Wish
Clinical Journal of the American Society of Nephrology : CJASN|August 8, 2018
Biosimilars-Emerging Role in NephrologyJay B Wish
Nephrology News & Issues|July 17, 2013
Management of anemia in patients with kidney disease in 2013 and beyondJay B Wish
Postgraduate Medicine|August 12, 2009
Management of anemia in patients with chronic kidney diseaseJay B Wish
Advances in Chronic Kidney Disease|February 24, 2009
Past, present, and future of chronic kidney disease anemia management in the United StatesJay B Wish
Kidney International Reports|October 8, 2021
Treatment of Anemia in Kidney Disease: Beyond ErythropoietinJay B Wish
Seminars in Dialysis|December 24, 2010
Vascular access for dialysis in the United States: progress, hurdles, controversies, and the futureJay B Wish
Blood Purification|January 14, 2011
What is expected of a medical director in the Centers for Medicare and Medicaid Services Conditions of Coverage?Jay B Wish
Nephrology News & Issues|March 22, 2014
The iron story: red smoke and magnetism?Jay B Wish
Advances in Chronic Kidney Disease|September 4, 2019
Anemia Treatment After 30 Years of Erythropoietic Stimulating Agents: No Longer Business as Usual?Jay B Wish
Pageof 9